Forskningsgrupper
Publikasjoner og forskningsresultater
Vitenskapelige publikasjoner
Marciuch, Anne; Birkeland, Bente; Saltyte Benth, Jurate; Solli, Kristin Klemmetsby; Tanum, Lars Håkon Reiestad; Mathisen, Ida; Weimand, Bente
(2023).
Personal recovery among people with opioid use disorder during treatment with extended-release naltrexone.
Heliyon.
Vol. 9.
https://doi.org/10.1016/j.heliyon.2023.e17516
Weimand, Bente Margrethe; Karlsson, Ann Tarja; Solli, Kristin Klemmetsby; Vederhus, John-Kåre; Mordal, Jon; Digranes, Linn Camilla Wergeland; Tanum, Lars Håkon Reiestad (2023). Characteristics of opioid-dependent patients choosing antagonist treatment with extended-release naltrexone compared with patients in opioid maintenance treatment in Norway. 9 s. Heroin Addiction and Related Clinical Problems. Vol. 25.
Broekhof, Rosalie; Nordahl, Hans Morten; Tanum, Lars Håkon Reiestad; Selvik, Sara Germans
(2023).
Adverse childhood experiences and their association with substance use disorders in adulthood: A general population study (Young-HUNT).
Addictive Behaviors Reports.
Vol. 17.
https://doi.org/10.1016/j.abrep.2023.100488
Karlsson, Ann Tarja; Vederhus, John-Kåre; Clausen, Thomas; Weimand, Bente Margrethe; Solli, Kristin Klemmetsby; Tanum, Lars Håkon Reiestad
(2022).
Impact of Impulsivity, Hyperactivity, and Inattention on Discontinuation Rate among Opioid-Dependent Patients Treated with Extended-Release Naltrexone.
7 s.
International Journal of Environmental Research and Public Health (IJERPH).
Vol. 19.
https://doi.org/10.3390/ijerph191811435
Marciuch, Anne; Brenna, Ida Halvorsen; Weimand, Bente; Solli, Kristin Klemmetsby; Tanum, Lars Håkon Reiestad; Røstad, Bente; Birkeland, Bente
(2022).
Patients’ experiences of continued treatment with extended-release naltrexone: a Norwegian qualitative study.
14 s.
Addiction science & clinical practice.
Vol. 17.
https://doi.org/10.1186/s13722-022-00317-2
Latif, Zill-E-Huma; Skjærvø, Ingeborg; Solli, Kristin Klemmetsby; Tanum, Lars Håkon Reiestad
(2021).
Chronic Pain Among Patients With an Opioid Use Disorder.
American Journal on Addictions.
Vol. 30.
https://doi.org/10.1111/ajad.13153
Weimand, Bente; Solli, Kristin Klemmetsby; Reichelt, Wenche Helleren; Tanum, Lars Håkon Reiestad
(2021).
Enablers and hindrances for longer-term abstinence in opioid dependent individuals receiving treatment with extended-release naltrexone: A Norwegian longitudinal recovery trial (NaltRec study).
Contemporary Clinical Trials Communications.
Vol. 21.
https://doi.org/10.1016/j.conctc.2021.100728
Brenna, Ida Halvorsen; Marciuch, Anne; Birkeland, Bente; Veseth, Marius; Røstad, Bente; Løberg, Else-Marie; Solli, Kristin Klemmetsby; Tanum, Lars Håkon Reiestad; Weimand, Bente
(2021).
‘Not at all what I had expected’: Discontinuing treatment with extended-release naltrexone (XR-NTX): A qualitative study.
Journal of Substance Abuse Treatment.
https://doi.org/10.1016/j.jsat.2021.108667
Gaulen, Zhanna; Saltyte Benth, Jurate; Fadnes, Lars T.; Brenna, Ida Halvorsen; Tanum, Lars Håkon Reiestad
(2021).
Life satisfaction among individuals with opioid use disorder receiving extended-release naltrexone: A 12-week randomized controlled trial and a 36-week follow-up.
8 s.
Journal of Substance Abuse Treatment.
https://doi.org/10.1016/j.jsat.2021.108656
Karlsson, Ann Tarja; Vederhus, John-Kåre; Clausen, Thomas; Weimand, Bente; Solli, Kristin Klemmetsby; Tanum, Lars Håkon Reiestad
(2021).
Levels of impulsivity, hyperactivity, and inattention and the association with mental health and substance use severity in opioid-dependent patients seeking treatment with extended-release naltrexone.
8 s.
Journal of Clinical Medicine.
Vol. 10.
https://doi.org/10.3390/jcm10194558